Short Interest in Carmell Co. (NASDAQ:CTCX) Decreases By 33.3%

Carmell Co. (NASDAQ:CTCX) saw a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 105,000 shares, a drop of 33.3% from the November 30th total of 157,500 shares. Based on an average daily trading volume, of 5,770,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.8% of the shares of the company are short sold.

Hedge Funds Weigh In On Carmell

A hedge fund recently bought a new stake in Carmell stock. Warberg Asset Management LLC bought a new position in shares of Carmell Co. (NASDAQ:CTCX) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned 0.22% of Carmell at the end of the most recent reporting period. Institutional investors own 24.22% of the company’s stock.

Carmell Trading Down 5.1 %

Shares of Carmell stock opened at $0.31 on Monday. The firm has a 50-day simple moving average of $0.29 and a two-hundred day simple moving average of $0.71. Carmell has a fifty-two week low of $0.20 and a fifty-two week high of $4.00.

Carmell Company Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.